PMID: 1195276Dec 1, 1975Paper

Structure-activity relationships of antiarrhythmic 6-substituted decahydroisoquinolines

Journal of Medicinal Chemistry
I W Mathison, R R Tidwell

Abstract

A series of diastereoisomeric 6-benzoyloxy- and 6-benzamido-2-methyldecahydroisoquinolines has been prepared and screened for antiarrhythmic effectiveness. In a continuation of our interest in identifying significant physicochemical properties of antiarrhythmic decahydroisoquinolines, octanol-water partition coefficients and pKa values have been determined for each member of the series. In general, antiarrhythmic activities superior to that of quinidine were observed. From a general structure-activity viewpoint, substitutions possessing greater lipophilicities produced compounds with superior antiarrhythmic properties. However, there appears to be optimal lipophilic character beyond which increased lipophilicity results in a decrease in antiarrhythmic potency. No discernible correlations with pKa values were evident. As noted in our earlier studies the esters were more potent and more lipophilic than the corresponding amides. No obvious correlations with stereochemistry were found; however, in three pairs of diastereoisomers, the more lipophilic cis compounds were found to be the superior isomers. A surprisingly high potency was noted with a tetrahydroisoquinoline benzamide--a finding unexpected from our earlier work. The 3,4-d...Continue Reading

Citations

Nov 1, 1977·Molecular and Cellular Endocrinology·R Mathison, K Lederis
May 1, 1976·Journal of Pharmaceutical Sciences·P H Morgan, I W Mathison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.